(Q41060717)

26 September 2017

title

Generation and characterization of gp100 peptide-specific NK-T cell clones (English)

1 reference

26 September 2017

6

G Gaudernack

1 reference

26 September 2017

3

J H Myklebust

1 reference

26 September 2017

I Saeterdal

1

1 reference

26 September 2017

P thor Straten

series ordinal

2

1 reference

26 September 2017

A F Kirkin

series ordinal

4

1 reference

26 September 2017

M K Gjertsen

series ordinal

5

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

International Journal of Cancer

26 September 2017

published in

1 reference

26 September 2017

volume

75

1 reference

26 September 2017

issue

5

1 reference

26 September 2017

page(s)

794-803

1 reference

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980302%2975%3A5%3C794%3A%3AAID-IJC21%3E3.0.CO%3B2-5

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980302%2975%3A5%3C794%3A%3AAID-IJC21%3E3.0.CO%3B2-5

Oncogenic proteins as tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980302%2975%3A5%3C794%3A%3AAID-IJC21%3E3.0.CO%3B2-5

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980302%2975%3A5%3C794%3A%3AAID-IJC21%3E3.0.CO%3B2-5

MHC ligands and peptide motifs: first listing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980302%2975%3A5%3C794%3A%3AAID-IJC21%3E3.0.CO%3B2-5

Human tumor antigens recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980302%2975%3A5%3C794%3A%3AAID-IJC21%3E3.0.CO%3B2-5

Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980302%2975%3A5%3C794%3A%3AAID-IJC21%3E3.0.CO%3B2-5

Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980302%2975%3A5%3C794%3A%3AAID-IJC21%3E3.0.CO%3B2-5

Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980302%2975%3A5%3C794%3A%3AAID-IJC21%3E3.0.CO%3B2-5

Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980302%2975%3A5%3C794%3A%3AAID-IJC21%3E3.0.CO%3B2-5

Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980302%2975%3A5%3C794%3A%3AAID-IJC21%3E3.0.CO%3B2-5

Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980302%2975%3A5%3C794%3A%3AAID-IJC21%3E3.0.CO%3B2-5

Autoradiography using storage phosphor technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980302%2975%3A5%3C794%3A%3AAID-IJC21%3E3.0.CO%3B2-5

Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980302%2975%3A5%3C794%3A%3AAID-IJC21%3E3.0.CO%3B2-5

10.1002/(SICI)1097-0215(19980302)75:5<794::AID-IJC21>3.0.CO;2-5

21 January 2018

Identifiers

DOI

1 reference

26 September 2017

1 reference